JENAE HESSE: Open Payments
NPI 1912556051 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 22 payments from 8 companies in 2025. Trend: 2023 $1,215 · 2024 $1,400 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $176 |
| Amgen Inc. | 5 | $82 |
| Lilly USA, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: QULIPTA, VRAYLAR, EVENITY, MOUNJARO, TRELEGY ELLIPTA, OTEZLA, Wegovy, UBRELVY.
Industry payments across FL — which companies pay providers there.
